| Bioactivity | Anticancer agent 41 is a potent anticancer agent, shows a potent antitumor activity against MDA-MB-231 cell with an IC50 of 3.99 μM[1]. |
| Target | IC50: 3.99 μM (anticancer in MDA-MB-231 cell) |
| Name | Anticancer agent 41 |
| CAS | 1394077-28-1 |
| Formula | C25H18Br2N2O3 |
| Molar Mass | 554.23 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jia J, Yin H, Chen C, et al. Design, synthesis, and evaluation of a novel series of mono-indolylbenzoquinones derivatives for the potential treatment of breast cancer. Eur J Med Chem. 2022 Apr 16;237:114375. |
Anticancer agent 41
CAS: 1394077-28-1 F: C25H18Br2N2O3 W: 554.23
Anticancer agent 41 is a potent anticancer agent, shows a potent antitumor activity against MDA-MB-231 cell with an IC50
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.